Apple (NASDAQ: AAPL ) wants to move away from Samsung. This we know. While the South Korean conglomerate has many independent divisions, Apple doesn't like giving the component segment business while the smartphone segment is its most viable competitor. To that end, the surest signs yet have emerged that Apple has inked a three-year deal with Taiwan Semiconductor (NYSE: TSM ) .
The Mac maker is reportedly on board for 20-nanometer, 16-nanometer, and 10-nanometer production at TSMC over the next few years, compared to the current 32-nanometer process used at Samsung right now. Well, The Korea Economic Daily doesn't necessarily think that's the case, and now says that Samsung has scored a contract to supply Apple with 14-nanometer A9 chips in 2015. Those processors would power the future "iPhone 7."
The report does corroborate the news that Apple is going with TSMC for 20-nanometer production of A8 processors, but says Apple will be switching back to Samsung for the following generation. Samsung has a technological lead with its 14-nanometer process, giving Apple little choice but to get back with its biggest rival.
Top 5 Heal Care Stocks For 2014: Shamaran Petroleum Corp (SNM.V)
ShaMaran Petroleum Corp engages in the exploration and development of oil and gas properties in the Kurdistan Region of Iraq. It has working interests in the Pulkhana block covering an area of 529 square kilometers, Arbat block covering an area of 973 square kilometers, and Taza block comprising 511 square kilometers, as well as the Atrush block with an area of 269 square kilometers in the northern extension of the Zagros folded belt in Kurdistan. The company was formerly known as Bayou Bend Petroleum Ltd. and changed its name to ShaMaran Petroleum Corp. in October 2009. ShaMaran Petroleum Corp. is based in Vancouver, Canada.
Top 5 Heal Care Stocks For 2014: (FSM)
Fortuna Silver Mines Inc. engages in the mining and production silver and base metal in Latin America. Its primary assets consist of the Caylloma zinc/lead/silver mine, which is located to the northwest of Arequipa, Peru; and the San Jose silver/gold project that is located south of the city of Oaxaca, Mexico. The company was formerly known as Fortuna Ventures Inc. and changed its name to Fortuna Silver Mines Inc. in June 2005. Fortuna Silver Mines Inc. The company was incorporated in 1990 and is headquartered in Lima, Peru.
Top 5 Low Price Stocks To Buy Right Now: Crs Electronics Inc (LED.V)
CRS Electronics Inc. develops, manufactures, and sells light emitting diode (LED) lighting products for interior and exterior architectural lighting applications primarily in North America. It offers child safety systems for school buses; exterior lighting on school buses based on incandescent and LED technology; LED based space lighting products; and LED lamps and fixtures for retail and commercial markets. The company is also involved in the contract manufacturing of LED light boards. CRS Electronics Inc. was incorporated in 1998 and is headquartered in Richmond Hill, Canada.
Top 5 Heal Care Stocks For 2014: U.S. Bancorp(USB)
U.S. Bancorp, a financial services holding company, provides various banking and financial services in the United States. It generates various deposit products, including checking accounts, savings accounts, money market savings, and time certificates of deposit accounts. The company originates a portfolio of loans comprising commercial loans and lease financing; commercial real estate; residential mortgage; and retail loans consisting of credit cards, retail leasing, home equity and second mortgages, and other retail loans. It also offers wholesale lending, equipment finance, small-ticket leasing, depository, treasury management, capital markets, foreign exchange, and international trade services to middle market, large corporate, commercial real estate, and public sector clients. In addition, U.S. Bancorp provides telebanking and automated teller machine (ATM) services, as well as cash management services. The company, through other subsidiaries, provides trust, private banking, financial advisory, investment management, retail brokerage services, insurance, and custody and fund services; and payment services, including consumer and business credit cards, stored-value cards, debit cards, corporate and purchasing card services, consumer lines of credit, and merchant processing. U.S. Bancorp primarily serves individuals, estates, foundations, business corporations, and charitable organizations. It operates a network of approximately 3,031 banking offices and 5,310 ATMs. The company was founded in 1863 and is headquartered in Minneapolis, Minnesota.
Advisors' Opinion:- [By John Maxfield]
More than any other too-big-to-fail lender, however, Bank of America has grasped this. If you're a customer of the bank and have used its mobile app, then you know what I mean. It's far and away one of the best in the industry, second perhaps only to U.S. Bancorp (NYSE: USB ) , which regularly ranks at the top of the heap in this department.
Top 5 Heal Care Stocks For 2014: Halozyme Therapeutics Inc.(HALO)
Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of recombinant human enzymes that transiently modify tissue under the skin to facilitate injection of other therapies or correct diseased tissue structures for clinical benefits. The company primarily offers recombinant human hyaluronidase, an enzyme that degrades hyaluronan, which is a matrix component in the skin, and facilitates the dispersion and absorption of drugs and fluids. Its portfolio of products and product candidates are developed based principally on intellectual property covering the family of human enzymes known as hyaluronidases. The company also provides Ultrafast Insulin program, a Phase II clinical trial product for the treatment of diabetes mellitus; and Enhanze technology, a proprietary drug delivery platform for subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as sma ll molecules and fluids. It offers PEGPH20, a new molecular entity that is in Phase I trial for the systemic treatment of tumors; and HTI-501, a recombinant human proteinase, which is in Phase 1/2 clinical trial used for the treatment of edematous fibrosclerotic panniculopathy (cellulite). The company has collaborative partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc.; ViroPharma Incorporated; and Intrexon Corporation to apply Enhanze technology to the partners? biological therapeutic compounds. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.
Advisors' Opinion:- [By Maxx Chatsko]
The treatment will add to its quickly growing expertise in blood treatments and biologics. Speaking of which, Baxter and Halozyme (NASDAQ: HALO ) had HyQvia approved for marketing in Europe�earlier this year. The therapy boosts the immune systems of patients with primary and secondary immunodeficiencies, and combines multiple therapies -- both intravenous and subcutaneous -- into one subcutaneous product. It also allows patients to administer treatment at home every three to four weeks. In other words, it knocks the convenience category out of the park. Halozyme has had a tumultuous life on the public market, so this could be just the stabilizer shareholders need.
No comments:
Post a Comment